Carotid intima-media thickness: knowledge and application to everyday practice
1Canyons Medical Center, 9355 South 1300 E., Sandy, UT 84094, USA. mcobble@canyonsmedical.com
Insights
Carotid intima-media thickness (CIMT) screening detects subclinical atherosclerosis, aiding cardiovascular disease risk assessment. This noninvasive ultrasound measurement helps identify early disease, enabling timely intervention and prevention strategies.
Area of Science:
- Cardiology
- Vascular Imaging
- Preventive Medicine
Background:
- Heart disease remains a leading cause of death in the US.
- Traditional risk assessments may not detect atherosclerotic disease.
- Subclinical atherosclerosis requires advanced detection methods.
Purpose of the Study:
- To evaluate Carotid Intima-Media Thickness (CIMT) as a surrogate marker for atherosclerosis.
- To assess CIMT's value in clarifying cardiovascular disease (CVD) risk.
- To explore CIMT's role in early detection and prevention of CVD.
Main Methods:
- Utilizing B-mode ultrasound to measure CIMT.
- Assessing CIMT's association with CVD, stroke, and myocardial infarction.
- Analyzing CIMT's utility in intermediate and low-risk patients.
Main Results:
- CIMT is a noninvasive, cost-effective, and repeatable measure.
- CIMT is an independent predictor of stroke and myocardial infarction.
- CIMT aids in identifying subclinical disease and guiding prevention.
Conclusions:
- CIMT is valuable for clarifying CVD risk, especially in intermediate-risk patients.
- Screening with CIMT can benefit even low-risk individuals with risk factors.
- Early detection via CIMT allows for timely intervention and investigation of underlying causes.
Abstract:
Heart disease is the primary cause of death in the United States. Fortunately, intervention measures can reduce the risk of cardiovascular disease (CVD) after a patient has been accurately assessed. Atherosclerotic disease, one of the driving forces behind CVD, is not always detected by traditional risk assessment. Carotid intima-media thickness (CIMT), as measured by B-mode ultrasound, is a surrogate marker for atherosclerosis and can be used to detect an accelerated disease process and subclinical disease. Advantages of CIMT are that it is noninvasive, relatively inexpensive, and can be repeatedly performed with no adverse effects on the patient. Carotid intima-media thickness is associated with CVD and is an independent predictor of stroke and myocardial infarction. Therefore, CIMT is valuable for clarifying CVD risk, particularly for patients with intermediate risk by conventional risk assessment. Screening for subclinical disease even in low-risk patients may have benefit, especially for those with a family history of premature CVD or those with any of the National Cholesterol Education Program risk factors. The detection of subclinical atherosclerosis allows the physician to implement prevention efforts prior to a devastating CVD event and to investigate possible reasons for increased arterial thickening, such as an occult underlying insulin-resistant condition or residual lipid risk markers. Treatment with several types of drugs has been demonstrated to halt the progression or even reduce CIMT. Carotid intima-media thickness is currently limited by the lack of standardized protocols that may affect reproducibility from measure to measure. Efforts to draft a standardized protocol are underway by the Society of Atherosclerosis Imaging and Prevention that will address this issue. Carotid intima-media thickness provides a valuable tool for physicians to clarify the CVD risk of their patients. Practical implications of CIMT for everyday clinical practice are addressed.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Aneurysm III: Interprofessional Care
Atherosclerosis IV: Nursing Management

